Operational indicators for pulmonary tuberculosis diagnosis in people living with HIV before and after Xpert MTB/RIF implementation in the state of São Paulo, Brazil
Authors:
- Mariana Gaspar Botelho Funari de FariaMFMariana Gaspar Botelho Funari de Faria
- Rubia Laine de Paula AndradeRARubia Laine de Paula Andrade
- Karina Fonseca de Sousa LeiteKLKarina Fonseca de Sousa Leite
- Rafaele Oliveira BonfimRBRafaele Oliveira Bonfim
- Ana Beatriz Marques ValênçaAVAna Beatriz Marques Valênça
Open Access
- 7 June 2024
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 19 (6) , e0305063
Abstract
Tuberculosis (TB) in people living with HIV (PLHIV) is usually paucibacillary and the smear microscopy has limitations and may lead to high proportions of non-confirmed pulmonary tuberculosis (NC-PTB). Despite culture being the reference method, it usually takes 6 to 8 weeks to produce the results. This study aimed to analyze the effect of a rapid molecular test (Xpert) in the confirmatory rate of PTB among PLHIV, from 2010 to 2020, in São Paulo state, Brazil. This is an ecological study with time series analysis of the trend and the NC-PTB rates before and after Xpert implementation in 21 municipalities. The use of Xpert started and gradually increased after 2014, while the rate of NC-PTB in PLHIV decreased over this time, being more significant between late 2015 and mid-2017. The city of Ribeirão Preto stands out for having the highest percentage (75.0%) of Xpert testing among PLHIV and for showing two reductions in the NC-PTB rate. The cities with low Xpert coverage had a slower and smaller decrease in the NC-PTB rate. Despite being available since 2014, a significant proportion of PLHIV suspected of PTB in the state of São Paulo did not have an Xpert ordered by the doctors. The implementation of Xpert reduced the NC-PTB rates with growing effect as the coverage increased in the municipality.Keywords
Funding Information
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (Financial Code 001)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (Financial Code 001)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (317170-2021-0)
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2022/00025-2)
This publication has 23 references indexed in Scilit:
- Population-Level Impact of Same-Day Microscopy and Xpert MTB/RIF for Tuberculosis Diagnosis in AfricaPLOS ONE, 2013
- Sputum induction to aid diagnosis of smear-negative or sputum-scarce tuberculosis in adults in HIV-endemic settingsEuropean Respiratory Journal, 2013
- Rapid molecular TB diagnosis: evidence, policy making and global implementation of Xpert MTB/RIFEuropean Respiratory Journal, 2012
- Population Health Impact and Cost-Effectiveness of Tuberculosis Diagnosis with Xpert MTB/RIF: A Dynamic Simulation and Economic EvaluationPLOS Medicine, 2012
- Avaliação da utilidade clínica de novos testes diagnósticos em tuberculose: o papel dos ensaios clínicos pragmáticosJornal Brasileiro de Pneumologia, 2012
- The Quality of Modern Cross-Sectional Ecologic Studies: A Bibliometric ReviewAmerican Journal of Epidemiology, 2011
- Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation studyThe Lancet, 2011
- Containment of Bioaerosol Infection Risk by the Xpert MTB/RIF Assay and Its Applicability to Point-of-Care SettingsJournal of Clinical Microbiology, 2010
- Iniciativa STROBE: subsídios para a comunicação de estudos observacionaisRevista de Saúde Pública, 2010
- Opportunities and Challenges for HIV Care in Overlapping HIV and TB EpidemicsJAMA, 2008